BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33608143)

  • 1. Frailty Index for prediction of surgical outcome in ovarian cancer: Results of a prospective study.
    Inci MG; Anders L; Woopen H; Richter R; Guzel D; Armbrust R; Sehouli J
    Gynecol Oncol; 2021 May; 161(2):396-401. PubMed ID: 33608143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer.
    Di Donato V; Di Pinto A; Giannini A; Caruso G; D'Oria O; Tomao F; Fischetti M; Perniola G; Palaia I; Muzii L; Benedetti Panici P
    Gynecol Oncol; 2021 Apr; 161(1):4-10. PubMed ID: 33223220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chambers LM; Chalif J; Yao M; Chichura A; Morton M; Gruner M; Costales AB; Horowitz M; Chau DB; Vargas R; Rose PG; Michener CM; Debernardo R
    Gynecol Oncol; 2021 Aug; 162(2):368-374. PubMed ID: 34083027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery.
    Rutten IJ; Ubachs J; Kruitwagen RF; van Dijk DP; Beets-Tan RG; Massuger LF; Olde Damink SW; Van Gorp T
    Eur J Surg Oncol; 2017 Apr; 43(4):717-724. PubMed ID: 28159443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study.
    Anic K; Varchola J; Schmidt MW; Schwab R; Linz VC; Schmidt M; Hardt R; Hartmann EK; Ruckes C; Hasenburg A; Battista MJ
    Arch Gynecol Obstet; 2023 Jun; 307(6):1929-1940. PubMed ID: 36434440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frailty and postoperative complications in older Chinese adults undergoing major thoracic and abdominal surgery.
    Han B; Li Q; Chen X
    Clin Interv Aging; 2019; 14():947-957. PubMed ID: 31190780
    [No Abstract]   [Full Text] [Related]  

  • 7. Frailty index predicts long-term mortality and postoperative complications in patients undergoing endovascular aortic aneurysm repair.
    Tse W; Newton D; Amendola M; George M; Pfeifer J
    J Vasc Surg; 2020 Nov; 72(5):1674-1680. PubMed ID: 32169360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.
    Elzarkaa AA; Shaalan W; Elemam D; Mansour H; Melis M; Malik E; Soliman AA
    J Gynecol Oncol; 2018 Jul; 29(4):e47. PubMed ID: 29770618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific Regions, Rather than the Entire Peritoneal Carcinosis Index, are Predictive of Complete Resection and Survival in Advanced Epithelial Ovarian Cancer.
    Rosendahl M; Harter P; Bjørn SF; Høgdall C
    Int J Gynecol Cancer; 2018 Feb; 28(2):316-322. PubMed ID: 29324538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Fried Frailty Score predict postoperative morbidity and mortality in gynecologic cancer surgery? Results of a prospective study.
    Inci MG; Anders L; Heise K; Richter R; Woopen H; Sehouli J
    J Geriatr Oncol; 2021 Apr; 12(3):428-433. PubMed ID: 33032944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Frailty Index Can Be Used to Predict Adverse Outcomes and Mortality after Lower Extremity Bypass Surgery.
    Ali TZ; Lehman EB; Aziz F
    Ann Vasc Surg; 2018 Jan; 46():168-177. PubMed ID: 28739453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frailty based on the memorial Sloan Kettering Frailty Index is associated with surgical decision making, clinical trial participation, and overall survival among older women with ovarian cancer.
    Filippova OT; Tin AL; Alonso J; Vickers AJ; Tew WP; Gardner GJ; Sonoda Y; Roche KL; Zivanovic O; Chi DS; Shahrokni A
    Gynecol Oncol; 2021 Jun; 161(3):687-692. PubMed ID: 33773807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer.
    Kumar A; Langstraat CL; DeJong SR; McGree ME; Bakkum-Gamez JN; Weaver AL; LeBrasseur NK; Cliby WA
    Gynecol Oncol; 2017 Oct; 147(1):104-109. PubMed ID: 28734497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified predictive score based on frailty for mid-term outcomes in open total aortic arch surgery.
    Hiraoka A; Saito K; Chikazawa G; Totsugawa T; Tamura K; Ishida A; Sakaguchi T; Yoshitaka H
    Eur J Cardiothorac Surg; 2018 Jul; 54(1):42-47. PubMed ID: 29408989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty Phenotypes and Relations With Surgical Outcomes: A Latent Class Analysis.
    Sadiq F; Kronzer VL; Wildes TS; McKinnon SL; Sharma A; Helsten DL; Scheier LM; Avidan MS; Ben Abdallah A
    Anesth Analg; 2018 Oct; 127(4):1017-1027. PubMed ID: 30113393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
    Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
    BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frailty index is useful for predicting postoperative morbidity in older patients undergoing gastrointestinal surgery: a prospective cohort study.
    Gu C; Lu A; Lei C; Wu Q; Zhang X; Wei M; Wang Z
    BMC Surg; 2022 Feb; 22(1):57. PubMed ID: 35172806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery.
    Barber EL; Rutstein S; Miller WC; Gehrig PA
    Gynecol Oncol; 2015 Dec; 139(3):401-6. PubMed ID: 26432038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy.
    Lyons YA; Reyes HD; McDonald ME; Newtson A; Devor E; Bender DP; Goodheart MJ; Gonzalez Bosquet J
    Int J Gynecol Cancer; 2020 Jun; 30(6):845-852. PubMed ID: 32341114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.